Skip to content

Exploring the Modulatory Role of Brain State on the Prefrontal Response to Excitatory Stimulation

Systematic Assessment of the Modulatory Role of Brain State on the Prefrontal Response to Excitatory Stimulation: a Concurrent rTMS/fNIRS Pilot Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06750614
Enrollment
36
Registered
2024-12-27
Start date
2024-12-03
Completion date
2025-12-05
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult

Keywords

Intermittent Theta-burst Stimulation, iTBS, Brain State, Transcranial Magnetic Stimulation, TMS, Functional Near-infrared Spectroscopy (fNIRS)

Brief summary

Therapeutic repetitive transcranial magnetic stimulation (rTMS) for depression is well-supported, with multiple protocols approved by the United States Food and Drug Administration and global efforts aimed at boosting its antidepressant effects underway. However, there exists an under-reported aspect of clinical trials using rTMS: what are patients doing during each stimulation session? Here, the investigators begin this investigation with individuals without a history of depression nor other psychiatric diagnosis. The investigators focus on the underlying brain activity. The investigators will systematically assess the modulatory role of brain state on the brain's response to a session of rTMS by using a concurrent, non-invasive brain imaging setting: functional near-infrared spectroscopy (fNIRS), marking the first effort of its kind in this field.

Detailed description

The scientific literature on rTMS rehabilitation is steadily growing and new treatment protocols that aim to optimize rehabilitation efficacy as well as efficiency are emerging. However, no consideration to what patients should be doing during rTMS treatment sessions is given. These details are typically omitted in the literature, and advice is not given in recent guidelines. When details are reported, patients are assumed to enter a relaxed state during treatment. This assumption is highly problematic, especially for MDD because depression is an internalizing disorder, wherein emotional and cognitive dyscontrol are major features linked with abnormal activity of the dorsolateral prefrontal cortex (DLPFC), the region being stimulated. Indeed, instructing patients to concentrate on thoughts that exacerbate their depressive symptoms during stimulation diminishes the antidepressant treatment effect, and cognitive neuroscience research suggests the importance of considering the initial brain state when conducting behavioral and neuroimaging experiments with TMS. Attention to what occurs during stimulation is highly relevant but usually omitted in neuropsychiatric rehabilitation research. This proposal is a systematic assessment of the modulatory role of brain state on the prefrontal response to rTMS in healthy participants. Results from this study will inform whether the clinical literature on therapeutic rTMS is mistaken for not controlling for brain state, and provide proof-of-concept for future clinical trials and collaborative research proposals (CRF) for the treatment of neuropsychiatric disorders.

Interventions

In each visit, the intensity of the iTBS applied to the participant will be set at 70% of their individual resting motor threshold (rMT), with one session specifically targeting the left DLPFC.

Sponsors

The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18 to 65 * Biological and mental health, based on a clinical interview * Able to understand and follow instructions

Exclusion criteria

* Major internal diseases, neurological disorders, or mental disorders * Having a metal implant * Hearing problems or in-ear ringing * Pregnancy or breastfeeding * Any conditions that will contraindicate to iTBS or fNIRS

Design outcomes

Primary

MeasureTime frameDescription
Oxygenated hemoglobin (HbO) changeThrough study completion, an average of 1 yeariTBS-induced HbO change in the DLPFC measured by fNIRS

Secondary

MeasureTime frameDescription
Deoxygenated hemoglobin (HbR) changeThrough study completion, an average of 1 yeariTBS-induced HbR change in the DLPFC measured by fNIRS

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026